"GENEART provides integrated system solutions for DNA engineering and processing based on the gene synthesis technology platform to deliver improved drugs and biotech products. The services portfolio ranges from the production of optimized synthetic genes and the generation of gene variants and gene libraries in combinatorial biology (gene evolution) right through to the production of DNA-based agents.
"Markets and business areas
"GENEART's services are utilized by pharmaceutical and biotech companies, and research institutes on the following markets:
Red Biotechnology:
DNA-based drugs and recombinant vaccines
Protein drugs
White Biotechnology:
Biocatalysts (enzymes, e.g. for industrial processes and consumer goods)
Green Biotechnology
Production of biopharmaceuticals in plants
Transgenic plants